Sp986

PANEL DISCUSSION

Date
May 8, 2023
Explore related products in the following collection:

Society: AGA

GERD refractory to standard therapy is a common problem in clinical practice. The causes are multiple and there is a need for a rational evidence based approach to this problem. This session will focus on providing a clear definition of refractory GERD, potential etiologies, appropriate use of diagnostic testing and effective management strategies. LIVE STREAM SESSION

Presenters

Speaker Image for Arjan Bredenoord
Amsterdam UMC, University of Amsterdam
Speaker Image for David Armstrong
McMaster University
Speaker Image for Kristle Lynch
University of Pennsylvania
Speaker Image for Rena Yadlapati
University of California San Diego

Tracks

Related Products

Thumbnail for NOVEL CLINICAL RISK PREDICTION SCORE FOR LARYNGOPHARYNGEAL REFLUX
NOVEL CLINICAL RISK PREDICTION SCORE FOR LARYNGOPHARYNGEAL REFLUX
Discerning whether laryngeal symptoms are related to reflux (laryngopharyngeal reflux; LPR) is a challenge. Consequently, patients see numerous specialists, undergo multiple diagnostic tests and empirically trial proton pump inhibitors (PPIs), often with inconsistent response…
Thumbnail for INTERIM RESULTS FROM A FIRST-IN-HUMAN STUDY OF THE ANTI-IL-15 ANTIBODY CALY-002 FOR TREATING CELIAC DISEASE AND EOSINOPHILIC ESOPHAGITIS
INTERIM RESULTS FROM A FIRST-IN-HUMAN STUDY OF THE ANTI-IL-15 ANTIBODY CALY-002 FOR TREATING CELIAC DISEASE AND EOSINOPHILIC ESOPHAGITIS
INTRODUCTION Interleukin-15 (IL-15) is an important cytokine involved in tissue homeostasis and inflammation, and a potent regulator of innate and adaptive immune responses…
Thumbnail for DUPILUMAB IMPROVES HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF PRIOR HISTORY OF ESOPHAGEAL DILATION
DUPILUMAB IMPROVES HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF PRIOR HISTORY OF ESOPHAGEAL DILATION
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
Thumbnail for QUESTION AND ANSWER
QUESTION AND ANSWER
This session will provide an overview of the recent advances in diagnostic approaches to GERD, expansion in types and roles of diagnostic tools including ambulatory reflux monitoring, esophageal manometry, FLIP and MI in regards to GERD, and updates in guidelines and best practice advice…